Fig. 1From: Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South AfricaA Methods used for incidence rates of ARI, SARI and deaths in Kenya. B Estimated RSV-associated ARI and SARI rates per 100,000 person-years in Kenya by age group and medical status. Error bars show 95% CI valuesBack to article page